Skip to main content
Screener/Healthcare/Biotechnology

CPRX — Catalyst Pharmaceuticals, Inc.

NASDAQ
$28.77+0.64 (+2.28%)
Mid CapUnder $50HealthcareHigh ROELow BetaMost Profitable
$19.05
$32.56
$28.14
$28.78
EPS (TTM)$1.68
P/E Ratio17.12
Dividend Yield—
Market Cap$3.36B
Volume860K
Prev Close$28.13
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$152.6M$52.7M$0.4090.8%34.5%
Q3 '25$148.4M$52.8M$0.4282.9%35.6%
Q2 '25$146.6M$52.1M$0.4179.6%35.6%
Q1 '25$141.4M$56.7M$0.4587.3%40.1%
Q4 '24$141.8M$55.9M$0.4484.7%39.4%
Q3 '24$128.7M$43.9M$0.3585.0%34.1%
Q2 '24$122.7M$40.8M$0.3387.4%33.2%
Q1 '24$98.5M$23.3M$0.1987.3%23.6%
Get Your Daily Market Recap